CN106349331B - Bipyrene-based pH response self-assembly polypeptide nano material and preparation method and application thereof - Google Patents
Bipyrene-based pH response self-assembly polypeptide nano material and preparation method and application thereof Download PDFInfo
- Publication number
- CN106349331B CN106349331B CN201610709616.5A CN201610709616A CN106349331B CN 106349331 B CN106349331 B CN 106349331B CN 201610709616 A CN201610709616 A CN 201610709616A CN 106349331 B CN106349331 B CN 106349331B
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- nanomaterial
- nano material
- self
- bispyrene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 96
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 83
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 80
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 80
- 238000001338 self-assembly Methods 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims description 10
- 230000004044 response Effects 0.000 title description 4
- HOMLMZXKKDLNSB-UHFFFAOYSA-N 1-pyren-1-ylpyrene Chemical compound C1=CC(C=2C3=CC=C4C=CC=C5C=CC(C3=C54)=CC=2)=C2C=CC3=CC=CC4=CC=C1C2=C43 HOMLMZXKKDLNSB-UHFFFAOYSA-N 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 17
- 239000012216 imaging agent Substances 0.000 claims abstract description 16
- 238000011282 treatment Methods 0.000 claims abstract description 15
- 239000002121 nanofiber Substances 0.000 claims abstract description 12
- 230000004043 responsiveness Effects 0.000 claims abstract description 9
- 238000012984 biological imaging Methods 0.000 claims abstract description 8
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 7
- 239000002077 nanosphere Substances 0.000 claims abstract description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 23
- 206010028980 Neoplasm Diseases 0.000 claims description 18
- 239000007853 buffer solution Substances 0.000 claims description 11
- 201000011510 cancer Diseases 0.000 claims description 11
- 150000003384 small molecules Chemical class 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 7
- 235000014304 histidine Nutrition 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 150000002411 histidines Chemical class 0.000 claims description 6
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 6
- 239000012498 ultrapure water Substances 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 108010075875 amyloid beta-protein (16-20) Proteins 0.000 claims description 4
- 238000010532 solid phase synthesis reaction Methods 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims description 2
- 239000000835 fiber Substances 0.000 abstract description 9
- 238000011065 in-situ storage Methods 0.000 abstract description 9
- 238000003745 diagnosis Methods 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000014759 maintenance of location Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 27
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 25
- 239000000463 material Substances 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 12
- 238000003384 imaging method Methods 0.000 description 12
- 239000002105 nanoparticle Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 6
- 238000010253 intravenous injection Methods 0.000 description 6
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical group CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 238000001000 micrograph Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000037062 Polyps Diseases 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000001815 biotherapy Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000010226 confocal imaging Methods 0.000 description 2
- 238000000942 confocal micrograph Methods 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000007115 recruitment Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229940126586 small molecule drug Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RALAXQOLLAQGTI-UHFFFAOYSA-N 2-[[2-[[2-[[1-(2-amino-4-methylpentanoyl)pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]butanedioic acid Chemical compound CC(C)CC(N)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC=1C=CC=CC=1)C(=O)NC(CC(O)=O)C(O)=O)CC1=CC=CC=C1 RALAXQOLLAQGTI-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000003875 Wang resin Substances 0.000 description 1
- NERFNHBZJXXFGY-UHFFFAOYSA-N [4-[(4-methylphenyl)methoxy]phenyl]methanol Chemical compound C1=CC(C)=CC=C1COC1=CC=C(CO)C=C1 NERFNHBZJXXFGY-UHFFFAOYSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000006740 morphological transformation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000018305 neoplasm of myocardium Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Abstract
The polypeptide nano material has pH responsiveness, forms nano fibers by self-assembly in an environment with the pH being more than or equal to 1.0 and less than 8.0, is assembled into nanospheres in an environment with the pH being more than or equal to 8.0, can recruit hydrophobic micromolecule imaging agents and medicines, greatly improves the utilization rate of the micromolecule imaging agents and the medicines, can be converted into fibers in situ at diseased tissues or cell parts, can greatly prolong the retention time, can be used for biological imaging and treatment, provides a reliable diagnosis and targeted treatment method for disease treatment, and has wide application prospect.
Description
Technical Field
The invention belongs to the technical field of nano materials, relates to a polypeptide nano material and a preparation method and application thereof, and particularly relates to a pH response self-assembly polypeptide nano material based on bispyrene and a preparation method and application thereof.
Background
In recent years, the application of nano materials in the diagnosis and treatment of clinical diseases has received great attention. Polypeptide self-assembled nanomaterials are widely used in biological imaging and therapy due to their good biocompatibility and chemical diversity. And nano-materials of different sizes and morphologies have great influence on biological imaging and therapy. Such as nanoparticles, related studies have shown that when the size of the nanoparticles is in the range of 10-100nm, the circulation time of the nanoparticles in vivo is increased; when the nanometer size is 15-350nm, the nanometer particles can be targeted and gathered at the myocardial infarction, tumor and other inflammation parts; but such nanoparticles will be rapidly cleared by the targeted tissue. Moreover, the structure of the nanoparticles is a metastable state, and the morphology of the nanoparticles is transformed along with the change of time and other factors (enzyme, temperature, pH and the like). Secondly, compared with nanoparticles, nanofibers have better stability and are not easily removed in vivo, which can prolong the residence time of the material. By utilizing the property of the nano fiber, the nano fiber can be used for long-acting biological imaging and treatment. On the other hand, small molecule imaging agents and therapeutic drugs have certain hydrophobicity, which limits their biological applications. The current method of use for small molecule imaging agents and therapeutic drugs is to encapsulate them with polymeric nanomaterials, which also presents certain challenges for the controlled release of small molecule imaging agents and drugs. Therefore, it is necessary to develop a new strategy for tumor detection and treatment.
Therefore, in the field, it is expected that a polypeptide nano-material capable of being transformed in situ to form a fiber can be designed by combining the stability of the nano-fiber and the hydrophobicity of the small molecule drug, so as to be used for recruiting the hydrophobic small molecule material and be used for biological imaging and treatment, and the novel diagnosis and treatment strategy with potential has wide research significance.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a polypeptide nano material based on bispyrene and a preparation method and application thereof, in particular to a polypeptide nano material based on pH response self-assembly of the bispyrene and a preparation method and application thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
in one aspect, the invention provides a polypeptide nanomaterial based on pyrene, wherein the nanomaterial has a structure shown in formulas I-IV as follows:
wherein R is1Is a polypeptide sequence with multiple hydrogen bonds in the molecule, R2A polypeptide sequence consisting of histidine, R3Polyethylene glycol chain being hydrophilic, R1、R2And R3Are connected by amido bond.
The polypeptide nano material with the structure has pH responsiveness, can be converted in situ to form fibers, is used for recruiting hydrophobic small molecule imaging agents and medicines, and greatly improves the utilization rate of the small molecule imaging agents and the medicines for treatment.
Preferably, the donor of the bispyrene compound group in the polypeptide nanomaterial based on bispyrene is a bispyrene compound with a structure shown in a formula V:
Preferably, R1Comprises the following steps:
wherein
Represents the site of attachment of the group. That is, in the present invention, R1The donor structure of (a) is:
Preferably, R2The donor is a polypeptide consisting of 4-10 histidines, e.g. R2The donor of (a) is a polypeptide consisting of 4, 5, 6, 7, 8, 9 or 10 histidines, preferably a hexapeptide consisting of 6 histidines.
Preferably, R3The donor of (a) is a carboxyl-terminated polyethylene glycol having a weight average molecular weight of 300-2000, such as 300, 400, 500, 600, 700, 800, 900, 1000, 1200, 1400, 1600, 1800 or 2000.
On the other hand, the invention provides a preparation method of the polypeptide nano material based on the dipyryrene, which comprises the steps of taking resin as a carrier, taking a dipyryrene compound shown as a formula V and amino acid as raw materials, and preparing the polypeptide nano material based on the dipyryrene by using a solid-phase synthesis method.
In another aspect, the invention provides a pH-responsive self-assembly method of the polypeptide nanomaterial based on bispyrene, which comprises the following steps:
(1) dissolving a polypeptide nano material based on the dipyrene in an organic solvent to obtain a polypeptide nano material solution;
(2) adding the polypeptide nano material solution obtained in the step (1) into a buffer solution, and self-assembling the polypeptide nano material into nano fibers in the buffer solution with the pH value of more than or equal to 1.0 and less than 8.0; in the buffer solution with the pH value more than or equal to 8.0, the polypeptide nano material is self-assembled into nanospheres.
Preferably, the organic solvent in step (1) is any one or a combination of at least two of DMSO, DMF or 1, 4-dioxane, preferably DMSO.
Preferably, the concentration of the polypeptide nano material solution in the step (1) is 10-4-10-2M, e.g. 1X 10-4M、3×10-4M、5×10-4M、8×10-4M、1×10-3M、3×10-3M、5×10-3M、8×10-3M or 1X 10-2M。
Preferably, the self-assembly of step (2) is performed under ultrasound for a period of 1-10min, such as 1min, 2min, 3min, 4min, 5min, 6min, 7min, 8min, 9min or 10 min.
Preferably, the sonication in step (2) is maintained for 0.5-12h (e.g., 0.8h, 1h, 3h, 5h, 8h, 10h, 11h or 12h) at 20-40 ℃ (e.g., 22 ℃, 25 ℃, 28 ℃, 30 ℃, 32 ℃, 35 ℃ or 38 ℃).
The polypeptide nano material based on the bispyrene has pH responsiveness, can be self-assembled into different forms under different pH values, and compared with nano particles, the nano fiber or the nano sphere prepared by the invention has better stability, is not easy to be eliminated in organisms, has longer detention time in the organisms, and has good biocompatibility, EPR effect, good pH sensitivity and the capacity of recruiting hydrophobic small molecule drugs.
On the other hand, the invention provides application of the polypeptide nano material based on the dipyryrene in preparation of cancer treatment drugs and biological imaging agents.
The pH responsive polypeptide nano material provided by the invention can be converted in situ to form fibers based on the good sensitivity to pH, is used for recruiting hydrophobic small molecule imaging agents and medicines, greatly improves the utilization rate of the small molecule imaging agents and the medicines for treatment, and has wide application prospect.
Compared with the prior art, the invention has the following beneficial effects:
the polypeptid nano material based on the bispyrene has pH responsiveness, forms nano fibers by self-assembly in the environment of pH being more than or equal to 1.0 and less than 8.0, is assembled into nanospheres in the environment of pH being more than or equal to 8.0, can recruit hydrophobic micromolecule imaging agents and medicines, greatly improves the utilization rate of the micromolecule imaging agents and the treatment medicines, can be converted into fibers in situ at diseased tissues or cell parts, can greatly prolong the retention time, can be used for biological imaging and treatment, provides a reliable diagnosis and targeted treatment method for disease (especially cancer) treatment, and has wide application prospect.
Drawings
FIG. 1 is a mass spectrum of a polypeptide nanomaterial based on bispyrene prepared in example 1;
FIG. 2 is a fluorescence intensity curve obtained by a self-assembly capability test of the polypeptide nanomaterial based on bispyrene prepared in example 1;
FIG. 3 is a transmission electron microscope image of the polypepyrene-based polypeptide nanomaterial prepared in example 1 after self-assembly in ultrapure water (panel A) and a buffer solution (panel B) with pH of 6.0, wherein the scales in the panels A and B are both 100 nm;
FIG. 4 is a single photon laser confocal micrograph of cells incubated with Nile Red by the polyp-based polypeptide nanomaterial prepared in example 1, wherein A is a bright field confocal result of a cytosphere under a 405nm laser excitation condition, B is a green result of the polyp when 450-;
FIG. 5 is a scanning electron micrograph of the bispyrene-based polypeptide nanomaterial prepared in example 1 showing in-situ morphology transformation on the surface of cancer cells, wherein a B picture is an enlarged view of selected positions in a picture A, a scale of the picture A is 50 μm, and a scale of the picture B is 5 μm;
FIG. 6 is a graph showing the results of a small animal imaging experiment in which the polypeptidic nanomaterial based on bispyrene prepared in example 1 was used to recruit the fluorescent dye Nile Red; wherein, the A picture is an imaging result picture after intravenous injection of the polypeptide nano material based on the dipyryrene and the Nile red for 4h, and the B picture is an imaging result picture after intravenous injection of the polypeptide nano material based on the dipyryrene and the Nile red for 96 h;
FIG. 7 is a mass spectrum of the polypeptidic nanomaterial based on bispyrene prepared in example 6;
FIG. 8 is a fluorescence intensity profile obtained by a self-assembly capability test of the polypeptide nanomaterial based on bispyrene prepared in example 6;
fig. 9 is a transmission electron microscope image of the polypepyrene-based polypeptide nanomaterial prepared in example 6 after self-assembly in a buffer (panel a) and a buffer (panel B) with a pH of 6.0, wherein scales in the panels a and B are both 100 nm;
FIG. 10 is a single photon laser confocal micrograph of the double pyrene-based polypeptide nanomaterial prepared in example 6 after co-incubation with Nile Red on cells, wherein A is a bright field confocal result of a cytosphere under a 405nm laser excitation condition, B is a result of double pyrene green light when 450-550nm and C is a result of Nile Red light when 550-700nm are collected under the 405nm laser excitation condition;
FIG. 11 is a scanning electron micrograph of the bispyrene-based polypeptide nanomaterial of example 6 showing in situ morphological transformation on the surface of cancer cells, wherein panel B is an enlarged view of selected sites in panel A, the scale of panel A is 50 μm, and the scale of panel B is 5 μm;
fig. 12 is a graph showing the result of an imaging experiment on a small animal in which the polypeptidic nanophase material based on bispyrene prepared in example 6 was used to recruit the fluorescent dye nile red, in which a is a graph showing the imaging result after 4 hours of intravenous injection of the polypeptidic nanophase material based on bispyrene and nile red, and B is a graph showing the imaging result after 96 hours of intravenous injection of the polypeptidic nanophase material based on bispyrene and nile red.
Detailed Description
The technical solution of the present invention is further explained by the following embodiments. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
Example 1
In this example, the structure of the polypeptidic nanomaterial based on bispyrene is shown below:
that is, in the formula II provided by the present invention, R1The donor of (A) is KLVFF, R2The donor of (A) is a hexapeptide consisting of 6 histidines, R3The donor of (A) is a carboxyl-terminated polyethylene glycol having a molecular weight of 1000g mol-1。
The polypepyrene-based polypeptide nano material is synthesized by a solid-phase synthesis method of polypeptide, Wang resin is adopted, coupling is carried out by a coupling agent (azomethylmorpholine: DMF: 5: 95, volume ratio) according to the sequence of the polypeptide, wherein PEG with carboxyl and a polypepyrene compound are also reacted according to the coupling method of amino acid, and finally, the polypepyrene-based polypeptide nano material is obtained by trifluoroacetic acid cracking, rotary evaporation and ether purification.
The results of mass spectrometry characterization of the polypeptide nanomaterial based on bispyrene synthesized in this example are shown in fig. 1, from which it can be seen that the ion peak appearing in the figure satisfies the characteristic peak of the molecular weight of the material molecule, and the peak shape completely conforms to the characteristic peak of the PEG polymeric chain.
Example 2
In this example, the polypeptidic nanomaterial based on bispyrene prepared in example 1 was self-assembled, and the pH responsiveness of the material was examined.
Firstly, the self-assembly ability of the polypeptidic nanomaterial based on the bispyrene is tested, the polypeptidic nanomaterial based on the bispyrene prepared in the embodiment 1 is dissolved in DMSO to test the fluorescence intensity, then water is added for group assembly, the water and the organic phase are fully mixed after adding a certain amount of water, then the mixture is kept stand for one minute to test the fluorescence intensity, and the test result is shown in figure 2.
As can be seen from FIG. 2, H was added to the DMSO solution of the polypeptidic nanomaterial based on bispyrene2The fluorescence increases at O, indicating that the material changes from a monodisperse to an aggregate state.
The pH responsive self-assembly method of the polypeptide nano material based on the dipyryrene comprises the following steps:
weighing 5mg of polypeptid nano material based on the dipyrene, dissolving the polypeptid nano material in 10mL of DMSO solvent, respectively and quickly injecting the solution into 90mL of ultrapure water and buffer solution with the pH value of 6.0 by using an injector, carrying out ultrasonic treatment for 30 minutes, and standing for two hours to respectively obtain fluorescent nano particles and nano fiber dispersion liquid.
Fig. 3 is a transmission electron microscope image of the polypeptidic nanomaterial based on bispyrene prepared in example 1 after self-assembly in ultrapure water and a buffer solution with pH of 6.0, and it can be seen from fig. 3 that the polypeptidic nanomaterial based on bispyrene has pH responsiveness, and the morphology changes from nanoparticles to fibers under the condition that pH gradually changes to acidity.
Example 3
The polypeptide nano-material based on the bispyrene prepared in the example 1 is subjected to a cell confocal test to examine the recruitment condition of the polypeptide nano-material to drugs or imaging agents, and the method comprises the following steps:
cell suspensions were prepared, 1mL per confocal dish, and incubated overnight. Taking out the culture medium, adding 1mL of the culture medium with the polypeptide nano material concentration of 20 mu M based on the dipyrene, and standing overnight; the drug is replaced by Nile Red (Nile Red) with 20 mu M, the culture is carried out for 2 hours, PBS is used for cleaning for 3 times, the confocal imaging experiment is carried out, a 405nm laser channel is adopted, and the green light wave band of 450-.
The result is shown in FIG. 4, the cytosphere is incubated with the material and Nile red, and in the single-photon co-focusing experiment, when the cell is excited at 405nm, the cell is in a green light of the bispyrene when the cell is collected in the range of 450-550 nm; when the collection is carried out in the range of 550-700nm, the red light of the Nile red is displayed, namely FRET (fluorescence resonance energy transfer) occurs, which proves that the material can be greatly accumulated on the cell surface and effectively recruit the fluorescent dye of the Nile red.
Example 4
In this example, the transformation of the polypeptide nanomaterial based on bispyrene prepared in example 1 on the surface of cancer cells was examined by the following method:
a1% agarose gel solution (0.1g agarose in 10mL water) was prepared, heated to boiling, transferred quickly to a clean bench, and 100. mu.L agarose solution was added to each well of a 96-well plate. Then the ultraviolet lamp is turned on to irradiate for 30 min. MCF-7 cell suspensions were prepared by adding 2000 cells per well, 200. mu.L per well. Culturing for 7 days, taking out the culture medium, adding the polypeptide nano-material based on the dipyrene into each hole, wherein the concentration of the polypeptide nano-material is 20 mu M, the volume is 200 mu L, and culturing for 24 h. The cell spheres were removed, solidified for 2-3 hours with 20% glutaraldehyde solution (glutaraldehyde: PBS buffer 1:4), and dehydrated with 30%, 50%, 70%, 90%, 100% ethanol solution diluted with PBS sequentially for 10 minutes three times at each concentration. Then, water and ethanol were replaced with a tert-butanol solution 3 times for 10 minutes each. And finally, dropwise adding the treated cell mass experiment to a silicon wafer, drying, and scanning and observing.
The results are shown in fig. 5, and it can be seen that the polypeptide nanomaterial based on bispyrene prepared in example 1 undergoes in-situ transformation on the surface of cancer cells to form fibers.
Example 5
In this example, the imaging situation of the polypeptide nanomaterial based on bispyrene prepared in example 1 in the small animal body is examined, and the method is as follows:
mice were injected subcutaneously with about 106MCF-7 cells, used for establishing a mouse model for tumor growth. When the mouse tumor grew to around 5.0mm in diameter, it was started for the imaging experiment. Firstly, 200 mu L of medicine is injected into the vein, and the concentration is 200 mu M; after 8 hours, 200. mu.L of 20. mu.M Nile Red solution was injected intravenously, and immediately a small animal imaging experiment was performed, collecting the band 550-600 nm.
The results are shown in FIG. 6, which shows that: injecting Nile red after intravenous injection of the medicine, wherein a Nile red signal can be detected within 4h, which indicates that the material has the capability of recruiting fluorescent molecules; after 96h, signals of nile red can be detected at the tumor site of the mouse, which indicates that the material can be retained at the tumor site for a very long time and can recruit fluorescent molecules for cancer detection.
Example 6
In this example, the structure of the polypeptidic nanomaterial based on bispyrene is shown below:
that is, in formula IV provided by the present invention, R1The donor of (A) is KLVFF, R2The donor of (A) is a hexapeptide consisting of 6 histidines, R3The donor of (A) is a carboxyl-terminated polyethylene glycol having a molecular weight of 1000g mol-1。
The polypepyrene-based polypeptide nanomaterial was synthesized using the solid phase synthesis method for the polypeptide as described in example 1.
The results of mass spectrometry characterization of the polypeptide nanomaterial based on bispyrene synthesized in this example are shown in fig. 7, from which it can be seen that the ion peak appearing in the figure satisfies the characteristic peak of the molecular weight of the material molecule, and the peak shape completely conforms to the characteristic peak of the PEG polymeric chain.
Example 7
In this example, the polypeptide nanomaterial based on bispyrene prepared in example 6 was self-assembled, and the self-assembly ability and pH responsiveness of the material were examined.
Firstly, the self-assembly ability of the polypeptidic nanomaterial based on the bispyrene is tested, the polypeptidic nanomaterial based on the bispyrene prepared in the embodiment 6 is dissolved in DMSO to test the fluorescence intensity, then water is added for group assembly, the water and the organic phase are fully mixed after adding a certain amount of water, then the mixture is kept stand for one minute to test the fluorescence intensity, and the test result is shown in FIG. 8.
As can be seen from FIG. 8, H was added to the DMSO solution of the polypeptidic nanomaterial based on bispyrene2The fluorescence increases at O, indicating that the material changes from a monodisperse to an aggregate state.
The pH responsive self-assembly method of the polypeptide nano material based on the dipyryrene comprises the following steps:
compound 5mg was weighed and dissolved in 10mL DMSO solvent, and the solution was rapidly injected into 90mL ultrapure water and pH 6.0 buffer solution by syringe, sonicated for 30 minutes, and left for two hours to obtain fluorescent nanoparticle and nanofiber dispersions, respectively.
Fig. 9 is a transmission electron microscope image of the polypeptidic nanomaterial based on bispyrene prepared in example 6 after self-assembly in ultrapure water and a buffer solution with pH of 6.0, and it can be seen from fig. 9 that the polypeptidic nanomaterial based on bispyrene has pH responsiveness, and the morphology changes from nanoparticles to fibers under the condition that pH gradually changes to acidity.
Example 8
The polypeptide nano-material based on the bispyrene prepared in the example 6 is subjected to a cell confocal test to examine the recruitment condition of the polypeptide nano-material to drugs or imaging agents, and the method comprises the following steps:
cell suspensions were prepared, 1mL per confocal dish, and incubated overnight. Taking out the culture medium, adding 1mL of the culture medium with the polypeptide nano material concentration of 20 mu M based on the dipyrene, and standing overnight; the drug is replaced by Nile Red (Nile Red) with 20 mu M, the culture is carried out for 2 hours, PBS is used for cleaning for 3 times, the confocal imaging experiment is carried out, a 405nm laser channel is adopted, and the green light wave band of 450-.
The result is shown in FIG. 10, the cytosphere is incubated with the material and Nile red, and in the single-photon confocal experiment, when the cell is excited at 405nm, the cell is in a green light of the bispyrene when the cell is collected in the range of 450-550 nm; when the collection is carried out in the range of 550-700nm, the red light of the Nile red is displayed, namely FRET (fluorescence resonance energy transfer) occurs, which proves that the material can be greatly accumulated on the cell surface and effectively recruit the fluorescent dye of the Nile red.
Example 9
In this example, the transformation of the polypeptide nanomaterial based on bispyrene prepared in example 6 on the surface of cancer cells was examined by the following method:
a1% agarose gel solution (0.1g agarose in 10mL water) was prepared, heated to boiling, transferred quickly to a clean bench, and 100. mu.L agarose solution was added to each well of a 96-well plate. Then the ultraviolet lamp is turned on to irradiate for 30 min. MCF-7 cell suspensions were prepared by adding 2000 cells per well, 200. mu.L per well. After 7 days of culture, the medium was removed and a volume of 200. mu.L of medium with a drug concentration of 20. mu.M was added to each well and cultured for 24 hours. The cell spheres were removed, solidified for 2-3 hours with 20% glutaraldehyde solution (glutaraldehyde: PBS buffer 1:4), and dehydrated with 30%, 50%, 70%, 90%, 100% ethanol solution diluted with PBS sequentially for 10 minutes three times at each concentration. Then, water and ethanol were replaced with a tert-butanol solution 3 times for 10 minutes each. And finally, dropwise adding the treated cell mass experiment to a silicon wafer, drying, and scanning and observing.
The result is shown in fig. 11, which shows that the polypeptide nanomaterial based on bispyrene prepared in example 6 is transformed in situ on the surface of cancer cells to form fibers.
Example 10
In this example, the imaging situation of the polypeptide nanomaterial based on bispyrene prepared in example 6 in the small animal body is examined, and the method is as follows:
mice were injected subcutaneously with about 106MCF-7 cells, used for establishing a mouse model for tumor growth. When the mouse tumor grew to around 5.0mm in diameter, it was started for the imaging experiment. Firstly, 200 mu L of medicine is injected into the vein, and the concentration is 200 mu M; after 8 hours, 200. mu.L of 20. mu.M Nile Red solution was injected intravenously, and immediately a small animal imaging experiment was performed, collecting the band 550-600 nm.
The results are shown in FIG. 12, which shows that: injecting Nile red after intravenous injection of the medicine, wherein a Nile red signal can be detected within 4h, which indicates that the material has the capability of recruiting fluorescent molecules; after 96h, signals of nile red can be detected at the tumor site of the mouse, which indicates that the material can be retained at the tumor site for a very long time and can recruit fluorescent molecules for cancer detection.
The applicant states that the present invention is illustrated by the above examples to the polypeptide nanomaterial based on pH-responsive self-assembly of bispyrene and the preparation method and application thereof, but the present invention is not limited by the above examples, i.e. it does not mean that the present invention must be implemented by the above examples. It will be apparent to those skilled in the art that any modification of the present invention, equivalent substitutions of selected materials and additions of auxiliary components, selection of specific modes and the like, which are within the scope and disclosure of the present invention, are contemplated by the present invention.
Claims (4)
1. A polypeptide nanomaterial based on bispyrene, which is characterized in that the polypeptide nanomaterial has a structure shown as the following formula II:
R1the donor of (a) is KLVFF;
R2the donor of (a) is a hexapeptide consisting of 6 histidines;
R3the donor of (A) is a carboxyl-terminated polyethylene glycol having a molecular weight of 1000g mol-1；
The structural formula of the polypeptide nano material is specifically shown as follows:
the polypeptide nano material based on the dipyryrene has pH responsiveness, forms nanofibers through self-assembly in an environment with pH being 6.0, and can recruit hydrophobic small molecule imaging agents and drugs.
2. The method for preparing the polypepyrene-based polypeptide nanomaterial according to claim 1, wherein the polypepyrene-based polypeptide nanomaterial is prepared by taking resin as a carrier, taking a polypepyrene compound represented by the following formula V and amino acid as raw materials and utilizing a solid phase synthesis method;
3. the method for pH-responsive self-assembly of the bispyrene-based polypeptide nanomaterial of claim 1, the method comprising the steps of:
(1) dissolving a polypeptide nano material based on the dipyrene in DMSO to obtain a polypeptide nano material solution; the concentration of the polypeptide nano material solution in the step (1) is 1.6 multiplied by 10-4M；
(2) Adding the polypeptide nano-material solution obtained in the step (1) into a buffer solution, and self-assembling the polypeptide nano-material into nano-fibers in the buffer solution with the pH value of 6.0; in the buffer solution of ultrapure water, the polypeptide nano material is self-assembled into nanospheres;
the self-assembly in the step (2) is carried out under ultrasonic, and the ultrasonic time is 30 minutes; standing for two hours after ultrasonic treatment.
4. The use of the polypepyrene-based polypeptide nanomaterial of claim 1 in the preparation of a cancer treatment drug and a biological imaging agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610709616.5A CN106349331B (en) | 2016-08-23 | 2016-08-23 | Bipyrene-based pH response self-assembly polypeptide nano material and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610709616.5A CN106349331B (en) | 2016-08-23 | 2016-08-23 | Bipyrene-based pH response self-assembly polypeptide nano material and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106349331A CN106349331A (en) | 2017-01-25 |
| CN106349331B true CN106349331B (en) | 2020-05-15 |
Family
ID=57844502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610709616.5A Active CN106349331B (en) | 2016-08-23 | 2016-08-23 | Bipyrene-based pH response self-assembly polypeptide nano material and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106349331B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108042803B (en) * | 2017-12-19 | 2020-06-16 | 国家纳米科学中心 | Liposome dispersion liquid loaded with AIE molecules and preparation method and application thereof |
| CN108079299B (en) * | 2018-02-11 | 2020-12-01 | 国家纳米科学中心 | Composite nano particle and preparation method and application thereof |
| CN111494642B (en) * | 2019-01-30 | 2022-10-14 | 国家纳米科学中心 | Self-assembly material for in-situ construction of artificial extracellular matrix and preparation method and application thereof |
| CN110627912B (en) * | 2019-10-18 | 2022-03-08 | 国家纳米科学中心 | Bionic fiber network antibody self-assembly material and preparation method and application thereof |
| CN111358960B (en) * | 2019-12-02 | 2021-04-06 | 哈尔滨医科大学 | Double-targeting polypeptide and application thereof in resisting tumors and inhibiting tumor angiogenesis |
| CN111171115B (en) * | 2020-01-06 | 2022-05-27 | 山东大学 | Method for controlling reversible assembly of polypeptide crystal by adjusting pH value |
| CN111349145A (en) * | 2020-03-10 | 2020-06-30 | 北京工业大学 | Polypeptide molecule for preventing PD-L1 from being redistributed on tumor surface, preparation and application |
| CN111675749B (en) * | 2020-06-09 | 2022-04-15 | 江苏科技大学 | Polypeptide sequence and self-assembly material and application thereof |
| CN114560951A (en) * | 2022-03-28 | 2022-05-31 | 哈尔滨医科大学 | Polypeptide-based molecule for targeting fibronectin to start assembly and application thereof |
| CN114870027B (en) * | 2022-05-19 | 2023-05-16 | 重庆医科大学附属第二医院 | Application of dipyrene in preparation of ultrasonic touch sound sensitizer, peptide functional compound and preparation, preparation method and application method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102083800A (en) * | 2008-06-27 | 2011-06-01 | 阿维拉制药公司 | Heteroaryl compounds and uses thereof |
| CN103275697A (en) * | 2013-05-28 | 2013-09-04 | 陕西师范大学 | Di-pyrene amphiphilic fluorescent probe and synthesis method and application thereof |
| CN103690961A (en) * | 2013-12-10 | 2014-04-02 | 深圳先进技术研究院 | Intelligent amphiphilic polymer nano micelle and preparation method and application thereof |
| CN104276936A (en) * | 2013-07-12 | 2015-01-14 | 国家纳米科学中心 | Bis-pyrene compound and fluorescent nano-aggregate thereof and application of fluorescent nano-aggregate |
| CN105079806A (en) * | 2014-05-13 | 2015-11-25 | 中国科学院深圳先进技术研究院 | Carbon nanomaterial directly modified by polypeptide as well as preparation method and application thereof |
-
2016
- 2016-08-23 CN CN201610709616.5A patent/CN106349331B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102083800A (en) * | 2008-06-27 | 2011-06-01 | 阿维拉制药公司 | Heteroaryl compounds and uses thereof |
| CN103275697A (en) * | 2013-05-28 | 2013-09-04 | 陕西师范大学 | Di-pyrene amphiphilic fluorescent probe and synthesis method and application thereof |
| CN104276936A (en) * | 2013-07-12 | 2015-01-14 | 国家纳米科学中心 | Bis-pyrene compound and fluorescent nano-aggregate thereof and application of fluorescent nano-aggregate |
| CN103690961A (en) * | 2013-12-10 | 2014-04-02 | 深圳先进技术研究院 | Intelligent amphiphilic polymer nano micelle and preparation method and application thereof |
| CN105079806A (en) * | 2014-05-13 | 2015-11-25 | 中国科学院深圳先进技术研究院 | Carbon nanomaterial directly modified by polypeptide as well as preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| Reorganization of self-assembled supramolecular materials controlled by hydrogen bonding and hydrophilic–lipophilic balance;Pei-Pei Yang等;《J.Mater.Chem.B》;20160322;第4卷(第15期);2662-2668 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106349331A (en) | 2017-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106349331B (en) | Bipyrene-based pH response self-assembly polypeptide nano material and preparation method and application thereof | |
| Guan et al. | Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy | |
| Li et al. | Core-satellite metal-organic framework@ upconversion nanoparticle superstructures via electrostatic self-assembly for efficient photodynamic theranostics | |
| Wu et al. | Nanobody modified high-performance AIE photosensitizer nanoparticles for precise photodynamic oral cancer therapy of patient-derived tumor xenograft | |
| CN101608020A (en) | With the standby magnetic Fe that obtains of hydro-thermal legal system 3O 4Polymer sub-micron sphere and purposes | |
| Wang et al. | Magneto-fluorescent nanoparticles with high-intensity NIR emission, T 1-and T 2-weighted MR for multimodal specific tumor imaging | |
| CN106822924B (en) | Degradable nano micelle capable of MR-fluorescence bimodal imaging and preparation method and application thereof | |
| Zhang et al. | Hyaluronic acid functionalized nitrogen-doped carbon quantum dots for targeted specific bioimaging | |
| Wang et al. | Lipid coated upconverting nanoparticles as NIR remote controlled transducer for simultaneous photodynamic therapy and cell imaging | |
| Joshi et al. | Multifunctional silica nanoparticles for optical and magnetic resonance imaging | |
| CN105622620B (en) | A kind of preparation method of the porphyrin photosensitizer with visualization optical dynamic therapy characteristic | |
| CN111662711A (en) | Preparation method and application of red fluorescent carbonized polymer dots | |
| Shah | The nanomaterial toolkit for neuroengineering | |
| Wei et al. | Excitation-selectable nanoprobe for tumor fluorescence imaging and near-infrared thermal therapy | |
| Zhou et al. | Synthesis and self-assembly behavior of chlorophyll derivatives for ratiometric photoacoustic signal optimization | |
| CN106749518B (en) | Polypeptide nano material containing pyrene group and preparation method and application thereof | |
| Du et al. | Encapsulation-Dependent Enhanced Emission of Near-Infrared Nanoparticles Using in Vivo Three-Photon Fluorescence Imaging | |
| Zhu et al. | Recent advance in tailoring the structure and functions of self-assembled peptide nanomaterials for biomedical applications | |
| An et al. | Facile synthesis of near-infrared bodipy by donor engineering for in vivo tumor targeted dual-modal imaging | |
| Chang et al. | A highly effective in vivo photothermal nanoplatform with dual imaging-guided therapy of cancer based on the charge reversal complex of dye and iron oxide | |
| CN107303388B (en) | Diagnostic and therapeutic preparation based on near-infrared dye-hyaluronic acid complex | |
| CN108226048B (en) | Nano-particles with aggregation-induced light absorption enhancement phenomenon and synthesis method thereof | |
| CN110437821B (en) | Preparation method of targeted green fluorescent carbon quantum dots, product and application thereof | |
| CN110642865B (en) | Application of high-charge cationic porphyrin in preparation of PDT nano photosensitizer | |
| Rananaware et al. | Fullerene Derivatives for Drug Delivery Applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |